FDA Approves Boosters for Immunocompromised, Pfizer and Moderna Set to Reap Billions From Sales of Third Shot
The U.S. Food and Drug Administration authorized a third COVID shot for immunocompromised patients. The Pfizer and Moderna vaccines have not been fully approved, and neither company has completed late-stage clinical trials proving a third dose will work.
